1. Home
  2. ORKT vs GDTC Comparison

ORKT vs GDTC Comparison

Compare ORKT & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKT
  • GDTC
  • Stock Information
  • Founded
  • ORKT 2003
  • GDTC 2018
  • Country
  • ORKT Singapore
  • GDTC Singapore
  • Employees
  • ORKT N/A
  • GDTC N/A
  • Industry
  • ORKT
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORKT
  • GDTC Health Care
  • Exchange
  • ORKT NYSE
  • GDTC Nasdaq
  • Market Cap
  • ORKT 34.7M
  • GDTC 29.4M
  • IPO Year
  • ORKT 2024
  • GDTC 2023
  • Fundamental
  • Price
  • ORKT $1.23
  • GDTC $2.56
  • Analyst Decision
  • ORKT Strong Buy
  • GDTC Buy
  • Analyst Count
  • ORKT 1
  • GDTC 1
  • Target Price
  • ORKT $5.00
  • GDTC $5.00
  • AVG Volume (30 Days)
  • ORKT 6.9M
  • GDTC 20.3K
  • Earning Date
  • ORKT 10-16-2024
  • GDTC 01-01-0001
  • Dividend Yield
  • ORKT N/A
  • GDTC N/A
  • EPS Growth
  • ORKT N/A
  • GDTC N/A
  • EPS
  • ORKT N/A
  • GDTC N/A
  • Revenue
  • ORKT $3,904,592.00
  • GDTC $330,254.00
  • Revenue This Year
  • ORKT N/A
  • GDTC $14.71
  • Revenue Next Year
  • ORKT N/A
  • GDTC N/A
  • P/E Ratio
  • ORKT N/A
  • GDTC N/A
  • Revenue Growth
  • ORKT N/A
  • GDTC N/A
  • 52 Week Low
  • ORKT $0.62
  • GDTC $1.20
  • 52 Week High
  • ORKT $8.00
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • ORKT N/A
  • GDTC 46.58
  • Support Level
  • ORKT N/A
  • GDTC $2.46
  • Resistance Level
  • ORKT N/A
  • GDTC $2.94
  • Average True Range (ATR)
  • ORKT 0.00
  • GDTC 0.21
  • MACD
  • ORKT 0.00
  • GDTC -0.01
  • Stochastic Oscillator
  • ORKT 0.00
  • GDTC 38.71

About ORKT ORANGEKLOUD TECHNOLOGY INC

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: